论文部分内容阅读
目的:探讨益生菌治疗肠易激综合征(IBS)的安全性和有效性。方法:收集本院本科2005年5月到2011年6月的肠易激综合征患者240名,分为益生茵组(用益生菌+常规治疗,120例),对照组(常规治疗,120例),比较两组疗效及不良反应。结果:治疗3个疗程后,益生菌组115例有效,有效率95.83%,常规治疗组97例有效,有效率80.83%(P<0.05),未见不良反应。结论:益生菌能有效缓解IBS患者的症状且不良反应较少。
Objective: To investigate the safety and efficacy of probiotics in treating irritable bowel syndrome (IBS). Methods: A total of 240 patients with IBS from May 2005 to June 2011 were enrolled in this study. They were divided into probiotics group (probiotics + 120 cases), control group (120 cases) ), Compared the two groups efficacy and adverse reactions. Results: After three courses of treatment, 115 cases were effective and the effective rate was 95.83% in the probiotics group, 97 cases in the conventional treatment group were effective and the effective rate was 80.83% (P <0.05). No adverse reactions were observed. Conclusion: Probiotics can effectively relieve the symptoms of IBS patients with less adverse reactions.